artesunate brands

84 registered brands containing artesunate in Kenya.

artesunate

PubChem CID 6917864

Molecular formula: C19H28O8

Artesunate is metabolized to the active DHA. the endoperoxide bridge of DHA reacts with heme, generating free radicals which inhibit protein and nucleic acid synthesis of the _Plasmodium_ parasites during all erythrocytic stages. Reactions with these free radicals can also lead to alkylation of parasitic proteins such as a calcium adenosine triphosphatase and EXP1, a glutathione S-transferase. Two theories have been put forward for the mode of antimalarial action of the artemisinin antimalarials, in accodance with the known properties of peroxides with medicinal activity. The first assumes that the artemisinins must be activated by contact with either reduced haem (ferrous haem, Fe(ll)PPIX) or non-haem ferrous iron (exogenous iron), causing cleavage of the peroxide to generate oxygen-centered radicals (alkoxy radicals') which are the presumed to be converted into carbon-centered radicals by transfer of proximate hydrogen atoms from the periphery of the peroxide molecule. These carbon-centered radicals are then thought to alkylate sensitive, yet unspecified, biomolecules in the parasite. A second theory argues for a process in which the intact artemisinin binds to a site within a vital protein in the parasite. The act of binding causes the peroxide to be converted to hydroperoxide or similar open peroxide, which in accordance with known properties of such compounds, generates one or more active chemical entities, either oxidizing agents or oxygen transfer agents per se, or oxygen-centered free radicals. This would be associated with the binding process. In such a way, the artemisinins might act as (irreversibile) inhibitors. Iron may, or may not, be associated with the activation process. No specific biological target in the parasite has yet been identified in support of this theory, but it may be membrane-bound proteins. Artesunate is a water soluble derivative of artemisinin, an antimalarial compound isolated from the Chinese herb Qinghao (Artemisia annua). Artesunate is rapidly metabolized to dihydroartemisinin (DHA) in the body. Chemically, artesunate, and its active metabolite, DHA, are sesquiterpene lactones with a trioxane ring containing a peroxide bridge. The peroxide bridge appears to be essential for the antimalarial activity of artesunate. Structure-activity relationship studies show that the deoxy derivative of DHA (that lack the peroxide bridge) was 277-fold less active than DHA. The activity of deoxyartesunate was not measured. Deoxy derivatives of other artemisinin analogs were 10- to 1000-fold less active compared to the parent compounds. Artesunate increases superoxide anion production and lipid peroxidation in falciparum-infected erythrocytes in vitro. However, artesunate does not suppress the activity of antioxidant enzymes (superoxide dismutase, catalase, glutathione reductase, and glutathione peroxidase) in infected or uninfected erythrocytes. Erythrocytes infected with the ring or trophozoite forms in vitro accumulate 100- and 180- fold higher concentrations of DHA (12 nM ie, 3.40 ng/mL), respectively, compared to uninfected erythrocytes. These experiments were performed in a medium containing 10% human serum. The relevance of these findings to the uptake in vivo is unclear. The precise mechanism by which artesunate exhibits antiplasmodial activity is not understood. A 2025 systematic review notes Artesunate's pharmacological activities (antimalarial, antiparasite,antitumor, antivirus, antiinflammation, and antibacterial),and that it is a highly effective antimalarial agent with the potential to induce organ toxicity under certain conditions. The authors note that mechanisms of Artesunate-induced toxicity include oxidative stress, inflammation, and apoptotic signaling patthhways.They also note that Artesunate ameliorates MASH (Metabolic Dysfunction-Associated Steatohepatitis) by reducing inflammation and lipid accumulation by regulating NLRP3 inflammasome and reducing lipid accumulation (SREBP-1c, FAS).

Source: PubChem (NCBI) · compound 6917864

Product Manufacturer Status Country
ARTRIN 140MG TAB
ARTESUNATE 120MG + LUMEFANTRINE 20MG
Sanofi Aventis Registered Kenya
AUSNART 60 MG INJ
60MG
Aushnlife Registered Kenya
AZUNATE INJECTION 60MG
60MG
Sai Pharmaceuticals Registered Kenya
CO-ARINATE FDC ADULT
200 MG ARTESUNATE 500 MG SULFAMETHOXYPYRAZINE 25 MG PYRIMETHAMINE
Energia Pharma Registered Kenya
Co-Arinate FDC adult
Tablet
Dafra Pharma GMBH Retained Kenya
CO-ARINATE FDC JUNIOR
100 MG ARTESUNATE 250 MG SULFAMETHOXYPYRAZINE 125 MG PYRIMETHAMINE
Energia Pharma Registered Kenya
Co-Arinate FDC junior
Tablet
Dafra Pharma GMBH Retained Kenya
DUNATE INJECTION
60MG
Nairobi Enterprises Registered Kenya
FALCICARE
60MG
Kentons Registered Kenya
FALCIMON 100/270MG B/L
ARTESUNATE 100MG - AMODIAQUINE 270MG
Phillips Healthcare Registered Kenya
FALCIMON 25/67.5MG B/L
ARTESUNATE 25MG & AMODIAQUINE 67.5MG
Phillips Healthcare Registered Kenya
FALCIMON 50/135 B/L
ARTESUNATE 50MG , AMODIAQUINE 135MG
Phillips Healthcare Registered Kenya
FALCINIL
ARTESUNATE 60MG
Lords Healthcare Registered Kenya
GSUNATE INJECTION
ARTESUNATE 60MG
Theralife Pharma Registered Kenya
GSUNATE-120
ARTESUNATE 120 MG
Theralife Pharma Registered Kenya
GSUNATE-200
200MG
Theralife Pharma Registered Kenya
GSUNATE-50
EACH SUPPOSITORY CONTAINS: ARTESUNATE 50MG
Theralife Pharma Registered Kenya
INDART-120 INJECTION
120MG
Sai Pharmaceuticals Registered Kenya
INDART-60 INJECTION
60MG
Sai Pharmaceuticals Registered Kenya
INDART-60 PLUS
ARTESUNATE 60MG
Sai Pharmaceuticals Registered Kenya
LARINATE 120
EACH COMBIPACK CONTAINS: EACH VIAL CONTAINS: ARTESUNATE PH.INT. (STERILE) 120 MG
Sai Pharmaceuticals Registered Kenya
LARINATE INJECTION
60 MG PER VIAL
Sai Pharmaceuticals Registered Kenya
LYSUNATE INJECTION 60MG (COMBI-PACK)
60MG
Harleys Registered Kenya
M-SUNATE INJECTON
ARTESUNATE 60MG / VIAL
Dawa Registered Kenya
MACSUNATE AQ FORTE TABLETS
ARTESUNATE 100MG AMODIAQUINE HYDROCHLORIDE 270MG
Sai Pharmaceuticals Registered Kenya
MACSUNATE AQ JUNIOR TABLETS
50/135
Sai Pharmaceuticals Registered Kenya
MACSUNATE AQ KID TABLETS
25MG/67.5MG
Sai Pharmaceuticals Registered Kenya
MALART 60
60 MG
Zawadi Healthcare Registered Kenya
NOVOARTESUN-60
ARTESUNATE 60MG INJECTION + 1ML AMPOULE OF SODIUM BICARBONATE INJECTION 5% W/V + 5ML AMPOULE OF SODIUM CHLORIDE INJECTION 0.9% W/V
Novogen Supplies Registered Kenya
PLASMOTRIM-200 RECTOCAPS
ARTESUNATE 200 MG
Acino Pharma - Kenya
PLASMOTRIM-50 RECTOCAPS
ARTESUNATE 50 MG
Goodman Agencies Registered Kenya
PYRAMAX GRANULES FOR ORAL SUSPENSION
EACH SACHET OF PYRAMAX GRANULES FOR ORAL SUSPENSION CONTAINS 60 MG PYRONARIDINE TETRAPHOSPHATE AND 20 MG ARTESUNATE
Perspective Healthcare Registered Kenya
PYRAMAX TABLET
EACH PYRAMAX TABLET CONTAINS 180 MG OF PYRONARIDINE TETRAPHOSPHATE AND 60 MG OF ARTESUNATE.
Perspective Healthcare Registered Kenya
SUNAT 60 INJECTION
EACH COMBIPACK CONTAINS: ARTESUNATE INJECTION 60 MG EACH VIAL CONTAINS: ARTESUNATE 60 MG,SODIUM BICARBONATE INJECTION USP (1ML) EACH AMPOULE CONTAINS: SODIUM BICARBONATE USP 5% W/V , WATER FOR INJECTION USP .Q.S., SODIUM CHLORIDE INJECTION USP (5ML)
Shalina Healthcare Registered Kenya
12